KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natera (NTRA) Asset Writedowns and Impairment (2016 - 2021)

Historic Asset Writedowns and Impairment for Natera (NTRA) over the last 8 years, with Q2 2021 value amounting to $296000.0.

  • Natera's Asset Writedowns and Impairment rose 41034.48% to $296000.0 in Q2 2021 from the same period last year, while for Jun 2021 it was $521000.0, marking a year-over-year decrease of 8327.98%. This contributed to the annual value of $1.8 million for FY2022, which is 123461.54% up from last year.
  • Natera's Asset Writedowns and Impairment amounted to $296000.0 in Q2 2021, which was up 41034.48% from $316000.0 recorded in Q1 2021.
  • Natera's 5-year Asset Writedowns and Impairment high stood at $1.5 million for Q1 2018, and its period low was -$91000.0 during Q4 2020.
  • For the 5-year period, Natera's Asset Writedowns and Impairment averaged around $542636.4, with its median value being $316000.0 (2021).
  • Within the past 5 years, the most significant YoY rise in Natera's Asset Writedowns and Impairment was 127326.73% (2020), while the steepest drop was 12520.78% (2020).
  • Natera's Asset Writedowns and Impairment (Quarter) stood at $576000.0 in 2017, then soared by 168.06% to $1.5 million in 2018, then crashed by 76.62% to $361000.0 in 2019, then plummeted by 125.21% to -$91000.0 in 2020, then surged by 425.27% to $296000.0 in 2021.
  • Its Asset Writedowns and Impairment was $296000.0 in Q2 2021, compared to $316000.0 in Q1 2021 and -$91000.0 in Q4 2020.